PubMed · 2013 · 85 citations · 22 references
MedicineOncologyPharmacologyChemotherapyClinical PharmacologyInflammationAnti-inflammatory PharmacologyGastrointestinal Cancer PharmacotherapyInflammation PharmacologyInflammatory Bowel DiseaseMedicinal Plant KnowledgeRheumatoid ArthritisAnti-inflammatory ActivityAnti-inflammatory Natural ProductsAnticancer ChemotherapyAnticancer Natural ProductsClinical Trial ReportsClinical Utility AnalysisClinical Utility Assessment
Turmeric root has been used medicinally in China and India for thousands of years. The active components are thought to be the curcuminoids, primarily curcumin, which is commonly available worldwide as a standardized extract. This article reviews the pharmacology of curcuminoids, their use and efficacy, potential adverse effects, and dosage and standardization. Preclinical studies point to mechanisms of action that are predominantly anti-inflammatory and antineoplastic, while early human clinical trials suggest beneficial effects for dyspepsia, peptic ulcer, inflammatory bowel disease, rheumatoid arthritis, osteoarthritis, uveitis, orbital pseudotumor, and pancreatic cancer. Curcumin is well-tolerated; the most common side effects are nausea and diarrhea. Theoretical interactions exist due to purported effects on metabolic enzymes and transport proteins, but clinical reports do not support any meaningful interactions. Nonetheless, caution, especially with chemotherapy agents, is advised. Late-phase clinical trials are still needed to confirm most beneficial effects.
22
Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations
Medicine, Oncology, Pharmacology +10
Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers
Guido Shoba, David C. Joy, Thangam Joseph et al. · Planta Medica · 1998 · 1.9K citations
Dose escalation of a curcuminoid formulation
Christopher D. Lao, Mack T. Ruffin, Daniel P. Normolle et al. · BMC Complementary and Alternative Medicine · 2006 · 1.4K citations · Full text
Pharmacy, Pharmacology, Toxicology +13
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Navneet K. Dhillon, Bharat B. Aggarwal, Robert A. Newman et al. · Clinical Cancer Research · 2008 · 1.3K citations
Medicine, Oncology, Pharmacology +15
Phase I Clinical Trial of Oral Curcumin
Ricky A. Sharma, Stephanie A. Euden, Sharon L. Platton et al. · Clinical Cancer Research · 2004 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +13